Tania Jain

Assistant Professor

20122019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tania Jain is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis

Jain, T., Alahdab, F., Firwana, B., Sonbol, M. B., Almader-Douglas, D. & Palmer, J., Apr 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 4, p. 728-733 6 p.

Research output: Contribution to journalArticle

  • Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis

    Jain, T., Kunze, K. L., Temkit, M., Partain, D. K., Patnaik, M. S., Slack, J. L., Khera, N., Hogan, W. J., Roy, V., Noel, P., Leis, J. F., Sproat, L. Z., Fauble, V., Mesa, R. A. & Palmer, J., Feb 1 2019, In : Bone marrow transplantation. 54, 2, p. 204-211 8 p.

    Research output: Contribution to journalArticle

  • Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?

    Jain, T., Kunze, K. L., Khetarpal, B. K., McCallen, M. R., Betcher, J. A., Ofori, H. T., Khera, N., Slack, J. L., Leis, J. F., Sproat, L. Z., Noel, P. & Palmer, J., Jul 3 2019, In : Leukemia and Lymphoma. 60, 8, p. 2034-2041 8 p.

    Research output: Contribution to journalArticle

  • Monoclonal antibody utilization characteristics in patients with multiple myeloma

    Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan-Khan, A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

    Research output: Contribution to journalArticle